Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_provenance.
- NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_assertion description "[We conducted an international, randomized, double-blind, placebo-controlled trial evaluating the safety and efficacy of an anti-interleukin-5 monoclonal antibody, mepolizumab, in patients with the hypereosinophilic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_provenance.
- NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_assertion evidence source_evidence_literature NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_provenance.
- NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_assertion SIO_000772 18344568 NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_provenance.
- NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_assertion wasDerivedFrom befree-20140225 NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_provenance.
- NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_assertion wasGeneratedBy ECO_0000203 NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_provenance.
- befree-20140225 importedOn "2014-02-25" NP929012.RA_X6oNmcMkG7pMN2k6OPdAJTEKt6VfCTma7k_LxLZc5A130_provenance.